Quantitative diagnosis of HER2 protein expressing breast cancer by single-particle quantum dot imaging

Quantum Dot Surface Chemistry and Functionalization for Cell Targeting and Imaging

(2015) Regina Bilan et al.   BIOCONJUGATE CHEMISTRY

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

(2015) Sandra M. Swain et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictive diagnosis of the risk of breast cancer recurrence after surgery by single-particle quantum dot imaging

(2015) Kohsuke Gonda et al.   Scientific Reports

Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status

(2015) Huiyan Ma et al.   Cancer Medicine

Highly Sensitive Single Domain Antibody–Quantum Dot Conjugates for Detection of HER2 Biomarker in Lung and Breast Cancer Cells

(2014) Tatsiana Y. Rakovich et al.   ACS Nano

Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?

(2014) Elisavet Paplomata et al.   CANCER

Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer

(2014) Sheng-Rong Sun et al.   International Journal of Nanomedicine

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

(2014) Ian E Krop et al.   LANCET ONCOLOGY

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

(2012) Sunil Verma et al.   NEW ENGLAND JOURNAL OF MEDICINE

In vivo imaging of the molecular distribution of the VEGF receptor during angiogenesis in a mouse model of ischemia

(2011) Y. Hamada et al.   BLOOD

Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors

(2011) S. I. Rudnick et al.   CANCER RESEARCH

Nano-imaging of the lymph network structure with quantum dots

(2010) Makoto Hikage et al.   NANOTECHNOLOGY

In VivoNano-imaging of Membrane Dynamics in Metastatic Tumor Cells Using Quantum Dots

(2009) Kohsuke Gonda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Nanoengineering Approach for Investigation and Regulation of Protein Immobilization

(2008) Yih Horng Tan et al.   ACS Nano

Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined

(2008) E. D. Saad et al.   ANNALS OF ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER